Isolamento e identificacao da arctigenina a partir dos frutos da Arctium lappa L. e avaliacao de atividade citotoxica in vitro e hepatoprotetora em ratos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora
DOI
Abstract
Arctigenin is a lignan isolated from Arctium lappa L., this plant, belonging to family
Asteraceae is widely used in traditional chinese medicine. Publications suggest
numerous pharmacological activities of crude extracts of this plant and arctigenin as
anti-inflammatory activity, hepatoprotective, hypoglycemic, anticancer and
antimicrobial, however detailed studies of hepatoprotective activity have not yet been
widely developed. The aim of this study was the isolation and identification of
arctigenin obtained from the fruits of Arctium lappa L., to evaluate the cytotoxic in
vitro of arctigenin in cell culture of liver carcinoma (HepG-2) and assess the effects of
this isolated compound on liver injury by ligation bile duct (BDL). The crude
chloroform extract of Arctium lappa L. was obtained by soxhlet. To isolate the
compounds was held vacuum column and observed high concentration of arctiin, a
precursor of arctigenin. To obtain arctigenin, it was necessary to carry out a
hydrolysis to remove the glucose molecule present in arctiin. After, the molecule was
identified by 1H NMR and 13C, attaining excellent purity, and additionally, was
carried out his chromatographic profile by HPLC.. In vitro experiments show that the
arctigenin decreased cell viability by MTT assay and the Trypan blue on HepG-2
cells and did not cause cytotoxicity on NIH/3T3 cells. Adhesion testing by providing
collagen type I on HepG-2 was also carried out to observe the mechanisms involving
the antitumor activity of arctigenin. In vivo experiments were performed by surgery in
BDL rats, with n = 6 and divided into groups: sham control, sham arctigenin, control
BDL, arctigenin BDL and silymarin BDL. The treatment of animals was made for 48
hours and after this period, euthanized and blood and liver were collected for serum
biochemical assessments (AST, ALT, FA and TNF-α) and also tissue rating (MPO).
The methodology of extraction, isolation and obtaining arctigenin developed was
effective, decreased spending solvents and the time to get compounds. The trust
parameters analyzed by HPLC showed that the analytical method was specific and
reproducible, which contributes to quality control studies and bioanalytical assays.
The arctigenin demonstrated cytotoxic activity and anti-adhesion, and dependent
dose activity in HepG-2 cells, with IC 50 of 90.8 μM. No activity on NIH/3T3 cells,
demonstrating the specific action on HepG-2 cells. Results of BDL done in 48 hours
showed no significant results when comparing with control groups and positive
control, however, literature reports show that the arctigenin is a promising compound
and hepatoprotection studies for longer periods would complement the elucidation of
its activity.
Description
Keywords
Citation
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
